Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Generic nadolol approved

Sep. 6, 1996

CGS-28106 for hypertension and congestive heart failure

Sep. 6, 1996

Zambon selects a dopaminergic compound for evaluation in cardiovascular/renal disorders

Sep. 6, 1996

New angiotensin II antagonists from Kotobuki

Sep. 6, 1996

alpha1-Adrenoceptor blockers with advantages over prazosin

Sep. 6, 1996

Fujisawa discloses vasopressin antagonists

Sep. 6, 1996

CPC-111 clinical trial results disclosed

Aug. 30, 1996

MHC-II and related molecules for treating septic shock

Aug. 30, 1996

Kirin Brewery synthesizes agents for arteriosclerosis

Aug. 30, 1996

Endothelin converting enzyme inhibitor revealed by Schering-Plough

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...